Nina Akrap

R&D, AstraZeneca
Goeteborg, O, Sweden

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

Dual inhibition of DNA-PK and Polϴ boosts precision of diverse prime editing systems.

Dual inhibition of DNA-PK and Polϴ boosts precision of diverse prime editing systems.

Journal: Nature communications

Published: August 21, 2024

Modified pegRNAs mitigate scaffold-derived prime editing by-products.

Modified pegRNAs mitigate scaffold-derived prime editing by-products.

Journal: Nature communications

Published: August 07, 2024

Simultaneous inhibition of DNA-PK and Polϴ improves integration efficiency and precision of genome editing.

Simultaneous inhibition of DNA-PK and Polϴ improves integration efficiency and precision of genome editing.

Journal: Nature communications

Published: January 26, 2023

Harnessing DSB repair to promote efficient homology-dependent and -independent prime editing.

Harnessing DSB repair to promote efficient homology-dependent and -independent prime editing.

Journal: Nature communications

Published: September 03, 2021

Author Correction: Universal toxin-based selection for precise genome engineering in human cells.

Author Correction: Universal toxin-based selection for precise genome engineering in human cells.

Journal: Nature communications

Published: May 11, 2021

Distinct mechanisms of resistance to fulvestrant treatment dictate level of ER independence and selective response to CDK inhibitors in metastatic breast cancer.

Distinct mechanisms of resistance to fulvestrant treatment dictate level of ER independence and selective response to CDK inhibitors in metastatic breast cancer.

Journal: Breast cancer research : BCR

Published: November 16, 2020

Universal toxin-based selection for precise genome engineering in human cells.

Universal toxin-based selection for precise genome engineering in human cells.

Journal: Nature communications

Published: April 21, 2020

The mevalonate precursor enzyme HMGCS1 is a novel marker and key mediator of cancer stem cell enrichment in luminal and basal models of breast cancer.

The mevalonate precursor enzyme HMGCS1 is a novel marker and key mediator of cancer stem cell enrichment in luminal and basal models of breast cancer.

Journal: PloS one

Published: April 17, 2020

Robotic Mammosphere Assay for High-Throughput Screening in Triple-Negative Breast Cancer.

Robotic Mammosphere Assay for High-Throughput Screening in Triple-Negative Breast Cancer.

Journal: SLAS discovery : advancing life sciences R & D

Published: March 28, 2017

Cell Cycle and Cell Size Dependent Gene Expression Reveals Distinct Subpopulations at Single-Cell Level.

Cell Cycle and Cell Size Dependent Gene Expression Reveals Distinct Subpopulations at Single-Cell Level.

Journal: Frontiers in genetics

Published: June 07, 2016

Identification of Distinct Breast Cancer Stem Cell Populations Based on Single-Cell Analyses of Functionally Enriched Stem and Progenitor Pools.

Identification of Distinct Breast Cancer Stem Cell Populations Based on Single-Cell Analyses of Functionally Enriched Stem and Progenitor Pools.

Journal: Stem cell reports

Published: July 14, 2015

Properties of targeted preamplification in DNA and cDNA quantification.

Properties of targeted preamplification in DNA and cDNA quantification.

Journal: Expert review of molecular diagnostics

Published: July 02, 2015

Showing 1-12 of 13

Last Updated: 09/26/2026